Screening, Brief Intervention, and Referral to Treatment for Offenders
NCT ID: NCT01683643
Last Updated: 2017-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
800 participants
INTERVENTIONAL
2012-04-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings
NCT01883791
Screening, Brief Intervention, and Referral to Treatment for Drug Use
NCT01683227
Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico
NCT01131520
Implementation and Evaluation of SBIRT
NCT03560076
Validating Adolescent SBIRT Measures
NCT02981849
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The scientific aims of the study are:
1. Assess the effectiveness of SBIRT with offenders in terms of participation in brief intervention (if so indicated) and enrollment in treatment (if so indicated).
2. Assess the effectiveness of SBIRT with offenders in terms of drug use, criminal activity, and criminal justice involvement at 12 months following baseline.
3. Determine whether there are differences in acceptability, participation, and outcomes between men and women.
4. Determine the cost of providing the SBIRT intervention with this population.
The clinical aims of the study are:
1. To complement the use of SBIRT within Los Angeles County's substance abuse treatment system.
2. To expand prevention and treatment options for offenders with substance abuse problems.
To our knowledge, this would be the first rigorous test of SBIRT with an offender population.
We will recruit inmates at two Los Angeles County Sheriff jail facilities, one for men and one for women (25% of total sample), and randomly assign them to the treatment (SBIRT) group (N =400) or to the control (no intervention) group (N = 400). Baseline demographic data will be collected. Subjects in both groups will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Control subjects will receive only their risk score and informational materials regarding the health risks of substance use. Experimental subjects, in addition to their risk score and informational materials, will also receive a brief intervention and a referral to treatment appropriate to their risk score from trained health educators. The health educators will be provided by Homeless Health Care, Los Angeles. Twelve months after study admission, all study participants will be contacted for a follow-up interview. We will obtain records-based data on arrests and jail incarceration over the follow-up period from the Sheriff's Department and the California Department of Justice. We will also collect subject participation in publicly-funded treatment from the Substance Abuse Prevention and Control Division of the Los Angeles County Department of Health.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SBIRT Group
Baseline demographic data will be collected. Subjects will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Experimental subjects, in addition to their risk score and informational materials, will also receive a brief intervention and a referral to treatment appropriate to their risk score from trained health educators. The health educators will be provided by Homeless Health Care, Los Angeles.
SBIRT
Screening, brief intervention, and referral to treatment.
Control Group
Baseline demographic data will be collected. Subjects will be screened for substance use risk using The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Control subjects will receive only their risk score and informational materials regarding the health risks of substance use.
Control Group
Control subjects will receive only their risk score and informational materials regarding the health risks of substance use.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SBIRT
Screening, brief intervention, and referral to treatment.
Control Group
Control subjects will receive only their risk score and informational materials regarding the health risks of substance use.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age
* English or Spanish speaking
* Not subject to extended jail or prison sentence
* Able to provide informed consent to participate in the study
Exclusion Criteria
* Inability to communicate in either English or Spanish
* Refusal to complete Locator form for follow-up.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Prendergast
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Prendergast, Ph.D
Role: PRINCIPAL_INVESTIGATOR
UCLA Integrated Substance Abuse Programs
Jerry Cartier, M.A.
Role: STUDY_DIRECTOR
UCLA Integrated Substance Abuse Programs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Prendergast ML, McCollister K, Warda U. A randomized study of the use of screening, brief intervention, and referral to treatment (SBIRT) for drug and alcohol use with jail inmates. J Subst Abuse Treat. 2017 Mar;74:54-64. doi: 10.1016/j.jsat.2016.12.011. Epub 2016 Dec 30.
Prendergast ML, Cartier JJ. Screening, brief intervention, and referral to treatment (SBIRT) for offenders: protocol for a pragmatic randomized trial. Addict Sci Clin Pract. 2013 Oct 23;8(1):16. doi: 10.1186/1940-0640-8-16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.